Cargando…
Expression and prognostic characteristics of m(5)C regulators in low‐grade glioma
Glioma is the most common intracranial malignant tumour. A clear diagnosis and molecular targeted therapy are of great significance for improving the survival time and quality of life of patients with low‐grade glioma. 5‐methylcytosine methylation is one of the ways of RNA modification, but there ar...
Autores principales: | Li, Xiaozhi, Meng, Yutong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875931/ https://www.ncbi.nlm.nih.gov/pubmed/33400376 http://dx.doi.org/10.1111/jcmm.16221 |
Ejemplares similares
-
Construction of a SUMOylation regulator‐based prognostic model in low‐grade glioma
por: Li, Xiaozhi, et al.
Publicado: (2021) -
Survival analysis of immune-related lncRNA in low-grade glioma
por: Li, Xiaozhi, et al.
Publicado: (2019) -
The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma
por: Li, Ran, et al.
Publicado: (2023) -
SUMOylation Regulator-Related Molecules Can Be Used as Prognostic Biomarkers for Glioblastoma
por: Li, Xiaozhi, et al.
Publicado: (2021) -
Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma
por: Su, Xiaotao, et al.
Publicado: (2021)